Literature DB >> 20237816

Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study.

Souhila Bouaziz-Terrachet1, Amel Toumi-Maouche, Boubekeur Maouche, Safia Taïri-Kellou.   

Abstract

Stilbene analogs are a new class of anti-inflammatory compounds that effectively inhibit COX-2, which is the major target in the treatment of inflammation and pain. In this study, docking simulations were conducted using AutoDock 4 software that focused on the binding of this class of compounds to COX-2 protein. Our aim was to better understand the structural and chemical features responsible for the recognition mechanism of these compounds, and to explore their binding modes of interaction at the active site by comparing them with COX-2 co-crystallized with SC-558. The docking results allowed us to provide a plausible explanation for the different binding affinities observed experimentally. These results show that important conserved residues, in particular Arg513, Phe518, Trp387, Leu352, Leu531 and Arg120, could be essential for the binding of the ligands to COX-2 protein. The quality of the docking model was estimated based on the binding energies of the studied compounds. A good correlation was obtained between experimental logAr values and the predicted binding energies of the studied compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237816     DOI: 10.1007/s00894-010-0679-7

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  44 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

2.  Structural analysis of NSAID binding by prostaglandin H2 synthase: time-dependent and time-independent inhibitors elicit identical enzyme conformations.

Authors:  B S Selinsky; K Gupta; C T Sharkey; P J Loll
Journal:  Biochemistry       Date:  2001-05-01       Impact factor: 3.162

Review 3.  Cyclooxygenase (COX) inhibitors: a comparative QSAR study.

Authors:  Rajni Garg; Alka Kurup; Suresh Babu Mekapati; Corwin Hansch
Journal:  Chem Rev       Date:  2003-03       Impact factor: 60.622

4.  Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2.

Authors:  C Luong; A Miller; J Barnett; J Chow; C Ramesha; M F Browner
Journal:  Nat Struct Biol       Date:  1996-11

5.  Molecular cloning, functional expression, and selective regulation of ovine prostaglandin H synthase-2.

Authors:  V Zhang; M O'Sullivan; H Hussain; W T Roswit; M J Holtzman
Journal:  Biochem Biophys Res Commun       Date:  1996-10-14       Impact factor: 3.575

6.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.

Authors:  R G Kurumbail; A M Stevens; J K Gierse; J J McDonald; R A Stegeman; J Y Pak; D Gildehaus; J M Miyashiro; T D Penning; K Seibert; P C Isakson; W C Stallings
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

7.  The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor.

Authors:  P Prasit; Z Wang; C Brideau; C C Chan; S Charleson; W Cromlish; D Ethier; J F Evans; A W Ford-Hutchinson; J Y Gauthier; R Gordon; J Guay; M Gresser; S Kargman; B Kennedy; Y Leblanc; S Léger; J Mancini; G P O'Neill; M Ouellet; M D Percival; H Perrier; D Riendeau; I Rodger; R Zamboni
Journal:  Bioorg Med Chem Lett       Date:  1999-07-05       Impact factor: 2.823

8.  The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.

Authors:  G M Greig; D A Francis; J P Falgueyret; M Ouellet; M D Percival; P Roy; C Bayly; J A Mancini; G P O'Neill
Journal:  Mol Pharmacol       Date:  1997-11       Impact factor: 4.436

Review 9.  Nitric oxide-releasing nonsteroidal anti-inflammatory drugs: gastrointestinal-sparing potential drugs.

Authors:  Ratan Singh; Raj Kumar; D P Singh
Journal:  J Med Food       Date:  2009-02       Impact factor: 2.786

10.  Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids.

Authors:  K Yamagata; K I Andreasson; W E Kaufmann; C A Barnes; P F Worley
Journal:  Neuron       Date:  1993-08       Impact factor: 17.173

View more
  3 in total

1.  Lead compound design for TPR/COX dual inhibition.

Authors:  Abhay Krishna; Arpita Yadav
Journal:  J Mol Model       Date:  2012-05-16       Impact factor: 1.810

2.  Modeling holo-ACP:DH and holo-ACP:KR complexes of modular polyketide synthases: a docking and molecular dynamics study.

Authors:  Swadha Anand; Debasisa Mohanty
Journal:  BMC Struct Biol       Date:  2012-05-28

3.  Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity.

Authors:  Ericsson Coy-Barrera
Journal:  Biomolecules       Date:  2020-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.